Announcements

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

• Cancers;
• JCM;
• Cells;
• Diagnostics;
• Medical Sciences;
• Biomedicines;
• Geriatrics;
• Current Oncology;
• Hemato;
• Onco;
• CIMB;
• Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

Conference: WASOG 2023

Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders

Date: 19–21 June 2023

Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden

Booth: #7

MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.

WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.

The following MDPI journals will be represented:

• Biomedicines;
• Clinics and Practice;
• Diagnostics;
• Diseases;
• Genes;
• Healthcare;
• Hematology Reports;
• IJTM;
• JCM;
• Medicines;
• Reports.

Please reach out (diagnostics@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

• JCM;
• JPM;
• Kidney and Dialysis;
• Diagnostics;
• Clinics and Practice;
• Uro;
• Cells;
• BioChem;
• Transplantology.

MDPI will be attending the 64th Annual Spring Meeting of the Japanese Society of Clinical Cytology, which will be held from 9 to 11 June 2023 in Nagoya, Japan, at the Nagoya Congress Center.

The conference is the official annual meeting of the Japanese Society of Clinical Cytology (JSCC), which is an academic organization consisting of physicians specializing in cytology and cytotechnologists who perform cytology for the purposes of cancer diagnosis and screening. Physicians specializing in cytology that belong to the society include gynecologists, surgeons, internists, and pathologists as well as cytotechnologists.

In light of current trends, the theme of this annual meeting is “Be fascinated with the mastery of cytology!—Mastering the art and passing it on to the next generations”. Cytology is deeply related to cervical cancer screening in Japan. Raising the screening rate, improving and adhering to the screening management guidelines, including colposcopy, and increasing the vaccination rate are important issues for the eradication of cervical cancer. These preventive strategies for cervical cancer will be propagated in this meeting.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Diagnostics;
• Medicina;
• Medical Sciences.

Please do not hesitate to reach out (cells@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.c-linkage.co.jp/jscc2023/index.html.

Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy

MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Children;
• CIMB;
• Current Oncology;
• Diagnostics;
• Geriatrics;
• Healthcare;
• JCM;
• Medical Sciences.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.

Conference: The 112th Annual Meeting of the Japanese Society of Pathology
Date: 13–15 April 2023
Place: Shimonoseki, Japan

MDPI will be attending the 112th Annual Meeting of the Japanese Society of Pathology as an exhibitor. This meeting will be held in Shimonoseki, Japan, from 13 to 15 April 2023. This conference is held every year, and the theme of the 112th edition is “Doors to Overcoming Intractable Diseases: Potential of Pathology and Pathological Diagnostics”. The aim of this meeting is to provide an opportunity for all the members who chose the path of pathology to engage in hot discussions and introduce new perspectives to pathology and diagnostic pathology.

The following MDPI journals will be represented:

• Cancers;
• Diagnostics;
• JPM;
• Pathogens;
• CIMB;
• Pathophysiology.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://site2.convention.co.jp/112jsp/english/.

MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• Biomedicines;
• Cancers;
• Cells;
• Diagnostics;
• Current Oncology;
• JPM;
• JCM;
• Onco;
• CIMB;
• BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.